Takeda shares drop after scrapping development of diabetes drug (Bloomberg, 27 December 2013)

06 Jan 2014


Japanese pharma Takeda has announced it has dropped development of experimental diabetes drug TAK-875 (fasiglifam).

Full article


Share this story